FDA Final Rule: IRB Waiver of Informed Consent for Minimal-Risk Investigations

The Food and Drug Administration (“FDA”) expands informed consent exceptions with a final rule permitting institutional review board (“IRB”) waiver or alteration of elements for certain FDA-regulated minimal-risk clinical investigations….
By: Jones Day